Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Minoxidil can help regrow hair in alopecia areata patients.

Using both vertical and transverse sections for alopecia biopsies improves diagnosis without extra cost.

Some chemotherapy can cause permanent hair loss.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.